Institute of Molecular Biotechnology (IMBA)

The IMBA - Institute of Molecular Biotechnology is a research organization founded as a joint initiative of the Austrian Academy of Sciences and the pharmaceutical company Boehringer Ingelheim. IMBA uses model organisms and cutting-edge functional genomics to investigate fundamental molecular processes and their contribution to disease. In interdisciplinary research groups, IMBA pursues an integrative approach that combines functional screening, cellular RNAi, stem cell and imaging technologies with the knowledge to rapidly generate mouse disease models to examine the role of genes in physiology and pathogenesis. Numerous co-operations with leading academic and industrial partners are an integral part of IMBA’s strategy and commitment to deliver outstanding results from its basic research and to translate these discoveries into future human medicine. Potential fields of application include major disease areas such as inflammation, autoimmune disorders, cardiovascular and neurodegenerative diseases, and cancer. A strong emphasis on competition guarantees high-quality research: Non-permanent positions, international benchmarking and on-going internal and external project evaluations are key principles to develop IMBA into a leading Centre of Excellence for molecular biology research in Central Europe. IMBA and the Research Institute of Molecular Pathology (IMP) operate in close partnership under the umbrella of the IMP-IMBA Research Center. The new research facility at the Campus Vienna Biocenter and the world-class scientific services shared with the IMP offer a state-of-the-art infrastructure for scientists from more than 30 different countries who are dedicated to making a difference in research. IMBA is financed by the City of Vienna and the Austrian Government. The institute has been able to raise a significant share in third-party funds from national and European research sponsors and has also initiated activities to attract private sponsors.

Adresse	Dr. Bohr-Gasse 3 1030 Wien
Website	https://www.imba.oeaw.ac.at
Organisationstyp	Außeruniversitäre F&E
Mitarbeiter in F&E	150
Branchen	Biotechnologie
Zusätzliche Keywords	Asymmetric cell division and proliferation control in Drosophila, Mechanisms of RNA silencing in human cells, RNA-directed DNA elimination in Tetrahymena, Bones, Immunity and Cancer, Epigenetic Regulation by the Polycomb and Trithorax group proteins, Mechanisms underlying cell motility and guidance, Design and function of molecular machines